Home » Authors » Trista Morrison

Articles by Trista Morrison

Pozen Plummets On Second Approvable Letter For Trexima

Aug. 3, 2007

By Trista Morrison

Diagnostic Lab Firm Genoptix Files for $86.25 Million IPO

Aug. 2, 2007

By Trista Morrison

Diagnostic Lab Firm Genoptix Files for $86.25 Million IPO

Aug. 2, 2007

By Trista Morrison

Neuren Acquires Hamilton, Gets Phase II CNS Drug

Aug. 1, 2007

By Trista Morrison

Neuren Acquires Hamilton, Gets Phase II CNS Drug

Aug. 1, 2007

By Trista Morrison

Alnylam, Medtronic Expand Deal With RNAi Drug-Device Combos

July 31, 2007

By Trista Morrison

Alnylam, Medtronic Expand Deal With RNAi Drug-Device Combos

July 31, 2007

By Trista Morrison

NewCo News: Nuon Hits The Ground Running With Funding License Deal

July 30, 2007

By Trista Morrison

NewCo News: Nuon Hits The Ground Running With Funding License Deal

July 30, 2007

By Trista Morrison

Aspreva Restructures, Plans To Look Beyond CellCept

July 27, 2007

By Trista Morrison

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...